The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

CVS Health Corp

NYSE: CVS
Last

(U.S.) $89.43

Today's change+0.17 +0.20%
Updated November 21 1:54 PM EST. Delayed by at least 15 minutes.
 

CVS Health Corp

NYSE: CVS
Last

(U.S.) $89.43

Today's change+0.17 +0.20%
Updated November 21 1:54 PM EST. Delayed by at least 15 minutes.

CVS Health Corp up (U.S.)$0.17

CVS Health Corp is up today by (U.S.)$0.17 or 0.20% to (U.S.)$89.43. Over the last five days, shares have gained 0.33% and are currently 1.13% off of the 52-week high. Shares have outperformed the S&P 500 by 20.52% during the last year.

Key company metrics

  • Open(U.S.) $89.62
  • Previous close(U.S.) $89.25
  • High(U.S.) $89.97
  • Low(U.S.) $89.32
  • Bid / Ask(U.S.) $89.42 / (U.S.) $89.43
  • YTD % change+24.95%
  • Volume2,413,081
  • Average volume (10-day)3,792,546
  • Average volume (1-month)4,105,701
  • Average volume (3-month)4,354,877
  • 52-week range(U.S.) $64.95 to (U.S.) $90.45
  • Beta1.07
  • Trailing P/E23.08×
  • P/E 1 year forward19.86×
  • Forward PEG1.36×
  • Indicated annual dividend(U.S.) $1.10
  • Dividend yield1.23%
  • Trailing EPS(U.S.) $3.87
Updated November 21 1:54 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+3.39%

Based on its net profit margin of 3.39%, CVS Health Corp is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.20%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Retail - Drugs
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue35,02134,60232,68932,782
Total other revenue--------
Total revenue35,02134,60232,68932,782
Gross profit6,4686,3245,9426,331
Total cost of revenue28,55328,27826,74726,451
Total operating expense33,29632,39430,66530,573
Selling / general / administrative4,2224,1163,9184,122
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)521----0
Other operating expenses, total--------
Operating income1,7252,2082,0242,209
Interest income (expense), net non-operating-158-161-161-138
Gain (loss) on sale of assets--------
Other--------
Income before tax1,5722,0501,8662,074
Income after tax9481,2461,1291,262
Income tax, total624804737812
Net income9481,2461,1291,261
Total adjustments to net income--------
Net income before extra. items9481,2461,1291,262
Minority interest------0
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items9481,2461,1291,262
Inc. avail. to common incl. extra. items9481,2461,1291,261
Diluted net income9481,2461,1291,261
Dilution adjustment--------
Diluted weighted average shares1,1641,1741,1901,202
Diluted EPS excluding extraordinary itemsvalue per share0.811.060.951.05
Dividends per sharevalue per share0.280.280.280.23
Diluted normalized EPSvalue per share1.081.060.951.05